Polymorphic differences in the SOD-2 gene may affect the pathogenesis of nephropathy in patients with diabetes and

Annwyne Houldsworth1, Andrea Hodgkinson1, Steve Shaw2

  • 1Molecular Medicine Research Groups, Peninsula College of Medicine and Dentistry, Plymouth, United Kingdom.

Gene
|April 11, 2015
PubMed
Abstract

Insights

Polymorphisms in the antioxidant gene SOD-2 may influence diabetes complications. The CC genotype of SOD-2 appears to offer protection against diabetic nephropathy in type 1 diabetes mellitus patients.

Area of Science:

  • Genetics and Molecular Biology
  • Endocrinology
  • Oxidative Stress Research

Background:

  • Oxidative stress plays a key role in diabetes pathogenesis and complications.
  • Antioxidant gene polymorphisms may influence individual susceptibility to diabetes and its sequelae.
  • Understanding intracellular antioxidant defenses is crucial for effective diabetes management.

Purpose of the Study:

  • To investigate the association between SOD-2 gene polymorphisms and type 1 diabetes mellitus (T1DM).
  • To determine if specific SOD-2 genotypes confer protection against diabetic complications like nephropathy and retinopathy.
  • To compare genotype frequencies between T1DM patients and healthy controls.

Main Methods:

  • Genotyping of SOD-2 polymorphism (Ala/Val, C-9T substitution) in 278 T1DM patients and 135 healthy controls.
  • Analysis of genotype and allelic frequencies.
  • Comparison of frequencies between patient subgroups (diabetic controls, nephropathy, retinopathy) and healthy controls.
  • Assessment of Hardy Weinberg equilibrium.

Main Results:

  • A significant difference in C-9T genotype distribution was observed between T1DM patients and normal controls.
  • The CC genotype was significantly more prevalent in diabetic controls (11.3%) compared to patients with diabetic nephropathy (1.4%).
  • Healthy controls also showed a higher incidence of the CC genotype (11.4%) compared to patients with nephropathy (1.4%).

Conclusions:

  • The SOD-2 SNP (C-9T) leads to an alanine to valine amino acid change, affecting enzyme processing.
  • The CC genotype of SOD-2 suggests a protective role against the development of diabetic nephropathy.
  • The higher frequency of the CC genotype in healthy individuals may indicate a general antioxidant protective effect.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.4K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
154
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
114
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
127
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
78